Intervention

MANP

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting1

Common conditions6

Lead sponsors shown3

Clinical trials

4 shown

To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant HypertensionNCT06343298 · 2024-11-17

Enhancing the Natriuretic Peptide System in HFpEFNCT05279742 · 2022-11-04

ENROLLING_BY_INVITATION

Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive SubjectsNCT05247528 · 2021-12-20

MANP in Hypertension and Metabolic SyndromeNCT03781739 · 2017-08-18

Common conditions

Difficult to Control Hypertension2 Chronic Kidney Diseases1 Heart Failure With Preserved Ejection Fraction1 Hypertension1 Metabolic Syndrome1 Resistant Hypertension1

Leading sponsors

E-Star BioTech, LLC2 Horng Chen1 Mayo Clinic1

Trial status mix

COMPLETED2

ENROLLING_BY_INVITATION1

RECRUITING1

Phase mix

PHASE13

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.